The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Plasma lipidomic profiling of chemotherapy-induced peripheral neuropathy.
 
Nicole Yeung
No Relationships to Disclose
 
Hui-Ming Lin
No Relationships to Disclose
 
Hannah Timmins
No Relationships to Disclose
 
Tiffany Li
No Relationships to Disclose
 
David Goldstein
Honoraria - AstraZeneca; Boehringer Ingelheim; Sun Biopharma
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Seagen; sun biopharma
Research Funding - Amgen (Inst); Bayer (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); pfizer (Inst); Zucero Therapeutics (Inst)
 
Michael Friedlander
Honoraria - AstraZeneca; GlaxoSmithKline; MSD; Novartis
Consulting or Advisory Role - Abbvie; AstraZeneca; Eisai; GlaxoSmithKline; Incyclix Bio; Lilly; MSD; Novartis; Takeda
Speakers' Bureau - AstraZeneca; GlaxoSmithKline
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Novartis (Inst)
 
Michelle L. Harrison
Stock and Other Ownership Interests - CSL Limited (I)
Consulting or Advisory Role - Eisai (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst)
 
Kate Lynette Mahon
No Relationships to Disclose
 
Peter Meikle
Leadership - BCAL Diagnostics; BCAL Diagnostics (Inst)
Stock and Other Ownership Interests - Juvenescence Ltd; Juvenescence Ltd (Inst)
Consulting or Advisory Role - BCAL Diagnostics; BCAL Diagnostics (Inst); Juvenescence Ltd; Juvenescence Ltd (Inst)
Patents, Royalties, Other Intellectual Property - Juvenescence Ltd; Juvenescence Ltd (Inst)
 
Susanna Park
No Relationships to Disclose
 
Lisa Horvath
Employment - Connected Medical Solutions (I)
Leadership - Connected Medical Solutions (I)
Stock and Other Ownership Interests - Connected Medical Solutions (I); Imagion Biosystems
Honoraria - Astellas Pharma; Janssen
Consulting or Advisory Role - Bayer; Imagion Biosystems
Research Funding - Astellas Pharma
Patents, Royalties, Other Intellectual Property - Provisional patent Australian No. 2022902527 Prognostic Markers (plasma lipid prognostic signature in metastatic prostate cancer). Inventors: Horvath L, Meikle P, Scheinberg S, Lin HM, Sullivan D The patent is owned by the Chris O'Brien Lifehouse (my (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen-Cilag; MSD Oncology; Pfizer